0001628280-21-022995.txt : 20211112 0001628280-21-022995.hdr.sgml : 20211112 20211112084751 ACCESSION NUMBER: 0001628280-21-022995 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211109 FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLANAGAN JOSEPH GERARD CENTRAL INDEX KEY: 0001413644 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34746 FILM NUMBER: 211400088 MAIL ADDRESS: STREET 1: C/O NORTEL NETWORKS CORPORATION STREET 2: 195 THE WEST MALL CITY: TORONTO STATE: A6 ZIP: M9C 5K1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: R1 RCM INC. CENTRAL INDEX KEY: 0001472595 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741] IRS NUMBER: 020698101 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 401 NORTH MICHIGAN AVENUE STREET 2: SUITE 2700 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 312-324-7820 MAIL ADDRESS: STREET 1: 401 NORTH MICHIGAN AVENUE STREET 2: SUITE 2700 CITY: CHICAGO STATE: IL ZIP: 60611 FORMER COMPANY: FORMER CONFORMED NAME: Accretive Health, Inc. DATE OF NAME CHANGE: 20090918 4 1 wf-form4_163672484943846.xml FORM 4 X0306 4 2021-11-09 0 0001472595 R1 RCM INC. RCM 0001413644 FLANAGAN JOSEPH GERARD C/O R1 RCM INC. 434 W. ASCENSION WAY, 6TH FLOOR MURRAY UT 84123 1 1 0 0 President and CEO Common Stock 2021-11-09 4 M 0 82920 2.42 A 2593256 D Common Stock 2021-11-09 4 S 0 82920 25.502 D 2510336 D Common Stock 2021-11-10 4 M 0 62563 2.42 A 2572899 D Common Stock 2021-11-10 4 S 0 62563 25.279 D 2510336 D Common Stock 2021-11-11 4 M 0 93931 2.42 A 2604267 D Common Stock 2021-11-11 4 S 0 93931 25.598 D 2510336 D Stock Option (right to buy) 2.42 2021-11-09 4 M 0 82920 0 D 2026-10-03 Common Stock 82920.0 603953 D Stock Option (right to buy) 2.42 2021-11-10 4 M 0 62563 0 D 2026-10-03 Common Stock 62563.0 541390 D Stock Option (right to buy) 2.42 2021-11-11 4 M 0 93931 0 D 2026-10-03 Common Stock 93931.0 447459 D The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.12 to $25.61 per share. The reporting person undertakes to provide to R1 RCM Inc., any security holder of R1 RCM Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.08 to $25.53 per share. The reporting person undertakes to provide to R1 RCM Inc., any security holder of R1 RCM Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.30 to $25.80 per share. The reporting person undertakes to provide to R1 RCM Inc., any security holder of R1 RCM Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The stock options vested and became exercisable in equal annual installments on April 1, 2017, 2018, 2019 and 2020. /s/ E. Terry Platis, Attorney-in-Fact 2021-11-12